Molecular Cancer
Scope & Guideline
Connecting researchers to revolutionize cancer care.
Introduction
Aims and Scopes
- Molecular Mechanisms of Cancer:
The journal explores the intricate molecular pathways that contribute to cancer development, progression, and metastasis, including genetic mutations, epigenetic modifications, and signaling pathways. - Cancer Immunology and Immunotherapy:
A significant focus is on the immune system's role in cancer, including the mechanisms of immune evasion by tumors and the development of innovative immunotherapeutic strategies. - Non-coding RNAs and Circular RNAs:
Research on non-coding RNAs, particularly circular RNAs, is a core area, examining their roles in gene regulation, tumor progression, and potential as therapeutic targets. - Tumor Microenvironment and Metabolism:
The journal investigates the relationship between tumor cells and their microenvironment, including the metabolic reprogramming of cancer cells and the influence of stromal components on tumor behavior. - Liquid Biopsy and Biomarkers:
There is a strong emphasis on the development and validation of biomarkers for cancer diagnosis, prognosis, and treatment response, particularly through liquid biopsy technologies. - Targeted and Personalized Therapies:
Research on targeted therapies, including small molecules and biologics, is prevalent, focusing on identifying actionable mutations and developing personalized treatment approaches. - Translational and Clinical Research:
The journal aims to bridge basic research with clinical applications, promoting studies that translate laboratory findings into therapeutic strategies for cancer patients.
Trending and Emerging
- Circular RNAs and Their Therapeutic Potential:
Research on circular RNAs has surged, exploring their mechanisms in cancer biology and their potential as therapeutic targets and biomarkers. - Multi-Omics Approaches:
There is a growing trend towards integrating multi-omics analyses (genomics, transcriptomics, proteomics) to better understand cancer heterogeneity and inform personalized therapies. - Cancer Immunometabolism:
The intersection of cancer metabolism and immunology is gaining traction, with studies focusing on how metabolic pathways influence immune responses in the tumor microenvironment. - CRISPR and Gene Editing Technologies:
The application of CRISPR and other gene editing technologies in cancer research is rapidly expanding, focusing on their potential to create novel therapies and understand gene function in cancer. - Liquid Biopsy Innovations:
Innovative approaches to liquid biopsy are emerging, with research targeting circulating tumor DNA and exosomal RNA as non-invasive methods for cancer detection and monitoring. - Targeting the Tumor Microenvironment:
There is an increasing emphasis on understanding and targeting the tumor microenvironment, particularly the roles of cancer-associated fibroblasts and immune cells in tumor progression and therapy resistance. - Combination Therapies and Personalized Medicine:
Research is increasingly focused on combination therapies that leverage advances in genomics and immunotherapy, aiming for personalized treatment strategies that improve patient outcomes.
Declining or Waning
- Traditional Chemotherapy Mechanisms:
There has been a noticeable decrease in publications focusing solely on traditional chemotherapy mechanisms, as the field shifts towards exploring combination therapies and personalized approaches. - Basic Cancer Genetics without Functional Insights:
Research that merely catalogs genetic mutations in cancers without functional validation or therapeutic implications is less frequently seen, as the emphasis has shifted to understanding the functional consequences of these mutations. - In vitro Studies with Limited Clinical Relevance:
Studies that focus solely on in vitro models without robust links to clinical outcomes or translational potential are becoming less prevalent, as researchers prioritize more clinically relevant models. - Single-Target Therapies:
Interest in single-target therapies has waned, with a growing focus on combination therapies and multi-target strategies that address the complexity of cancer biology. - Historical Cancer Treatments:
Research centered on older treatment modalities without novel insights or improvements has decreased, as the field moves towards innovative therapies and precision medicine.
Similar Journals
Molecular Oncology
Advancing the Frontiers of Cancer Research.Molecular Oncology, published by WILEY, is a premier open-access journal that has been at the forefront of cancer research since its inception in 2007. With an impressive impact factor reflective of its outstanding contribution to the field, it holds a prestigious position in the Q1 category across multiple disciplines, including Cancer Research, Genetics, and Molecular Medicine. This journal is essential for researchers and professionals seeking to publish high-quality findings in a rapidly evolving area of study, underscored by its significant Scopus rankings that place it within the top percentiles of Oncology and Molecular Biology. As an open-access journal since 2017, it ensures that vital research is readily available to a global audience, thereby facilitating collaboration and knowledge dissemination among academic and clinical communities. With its commitment to innovative and impactful research, Molecular Oncology continues to be a critical resource for advancing our understanding of cancer biology and treatment.
CANCER AND METASTASIS REVIEWS
Illuminating Pathways in Oncology and MetastasisCancer and Metastasis Reviews, published by Springer, is a leading journal in the field of oncology and cancer research. With an impressive impact factor placing it in the Q1 category for both Cancer Research and Oncology as of 2023, this journal is ranked 29th out of 404 in Medicine, Oncology, and 22nd out of 230 in Biochemistry, Genetics, and Molecular Biology, reflecting its significant influence and prestige in the academic community. Established in 1982, the journal covers a wide spectrum of topics related to the mechanisms of cancer progression and metastasis, making it an essential resource for researchers, healthcare professionals, and students dedicated to understanding and tackling cancer. Although the journal does not provide open access options, the impactful research it publishes contributes to advances in therapeutic strategies and enhances the collective knowledge surrounding cancer pathophysiology. With research converging from 1982 to 2024, Cancer and Metastasis Reviews continues to be a vital platform for disseminating high-quality scientific information in the ever-evolving landscape of cancer research.
Cancer Research Communications
Empowering global collaboration in cancer research.Cancer Research Communications is an esteemed journal published by the American Association for Cancer Research, a leading organization in the field of oncology. This journal aims to advance knowledge in cancer research through the dissemination of high-quality, peer-reviewed articles that cover a wide range of topics related to cancer biology, treatment modalities, and prevention strategies. As an open-access journal, Cancer Research Communications ensures that vital research findings are accessible to a global audience, promoting collaboration and innovation within the scientific community. The journal serves as a crucial platform for researchers, professionals, and students to share their insights and foster the exchange of effective cancer therapies and methodologies. With a commitment to excellence, it plays a significant role in shaping the future of cancer research and therapeutic development.
ANTICANCER RESEARCH
Empowering Discovery in Anticancer ScienceANTICANCER RESEARCH, published by the International Institute of Anticancer Research, stands at the forefront of cancer-related scholarly communication. With ISSN 0250-7005 and E-ISSN 1791-7530, this esteemed journal has been serving the global research community since 1981, showcasing innovative research aimed at combating cancer through various therapeutic approaches and scientific inquiry. Based in Greece, the journal aims to disseminate vital findings in the fields of Cancer Research, Medicine, and Oncology, reflecting its notable categorization in the Q3 and Q2 quartiles as of 2023. Despite its rigorous peer-review process and the absence of open access, ANTICANCER RESEARCH remains a vital publication for researchers, clinicians, and students eager to stay updated on the evolving landscape of anticancer strategies. As it converges to its milestone year of 2024, the journal continues to enrich the discourse around cancer treatment and prevention, affirming its position as an essential resource for those dedicated to advancing knowledge in anticancer therapies.
Advances in Cancer Biology-Metastasis
Pioneering Pathways in Cancer Research.Advances in Cancer Biology-Metastasis is an emerging journal published by Elsevier, aimed at advancing our understanding of the complexities of cancer biology, with a specific focus on the mechanisms and pathways related to metastasis. With an E-ISSN of 2667-3940, this journal offers a platform for researchers, professionals, and students in the fields of Cancer Research and Cell Biology to disseminate innovative findings and discuss novel therapeutic approaches. Though currently classified in the Q4 quartile across both Cancer Research and Cell Biology categories, the journal aspires to enhance its impact through rigorous peer review and high-quality publication. Positioned to cover the years from 2021 to 2024, it seeks to bridge gaps in foundational knowledge and promote collaborative research efforts that could pivot the current understanding of cancer metastasis. Researchers are encouraged to take advantage of this platform to advocate for advancements in cancer biology, making significant contributions that can influence both academic and clinical practices.
CANCER GENE THERAPY
Transforming Cancer Care Through Genetic InsightsCancer Gene Therapy, published by SpringerNature, stands at the forefront of research in the fields of cancer research, molecular biology, and molecular medicine. With a robust impact factor reflecting its significant influence—ranking in the Q2 category for cancer research and Q1 for both molecular biology and molecular medicine—it serves as an essential resource for scholars and practitioners alike. Since its inception in 1994, the journal has dedicated itself to advancing the understanding and therapeutic application of genetic innovations in oncology. Notably, it holds distinguished Scopus ranks, placing it among the top tier journals in its categories, underscoring its importance to the scientific community. While open access options are not available, the compelling research published here offers invaluable insights into the latest advancements and strategies in cancer therapy. Engaging with *Cancer Gene Therapy* not only keeps professionals informed but also inspires future innovations in the quest for effective cancer treatments.
Blood Cancer Discovery
Pioneering Discoveries for a Cancer-Free TomorrowBlood Cancer Discovery is a premier academic journal published by the American Association for Cancer Research, dedicated to advancing the understanding of hematologic malignancies through cutting-edge research in the fields of oncology, biochemistry, and molecular biology. With an impressive impact factor and recognition as a Q1 journal across multiple disciplines, including cancer research and hematology, Blood Cancer Discovery serves as an essential platform for scholars and practitioners alike, facilitating impactful discourse and dissemination of pioneering findings. This open-access journal, established within the vibrant academic landscape of the United States, aims to bridge gaps in research and foster collaborations to ultimately enhance patient outcomes. Its Scopus rankings demonstrate its vital role in the critical advancement of cancer research and therapeutic development. By inviting contributions from a diverse range of disciplines, Blood Cancer Discovery is poised to drive innovation and inspire future advancements in understanding blood cancers.
CANCER INVESTIGATION
Pioneering insights in oncology for a healthier tomorrow.CANCER INVESTIGATION is a distinguished peer-reviewed journal published by Taylor & Francis Inc, dedicated to the advancing field of cancer research and oncology. With an ISSN of 0735-7907 and E-ISSN of 1532-4192, this journal has been a pivotal resource for professionals and researchers since its inception in 1983, continually contributing to the evolving landscape of cancer investigation until its convergence in 2024. CANCER INVESTIGATION boasts noteworthy rankings in 2023, including Q3 in Cancer Research and Q2 in Medicine (miscellaneous), highlighting its relevance and impact in these critical areas. The journal's commitment to disseminating innovative research and comprehensive reviews makes it an essential platform for those engaged in cancer studies and related disciplines. While currently not available as an open-access publication, CANCER INVESTIGATION remains an invaluable tool for understanding the complexities of cancer, offering insights that drive scientific advancements and improve patient outcomes.
Oncogenesis
Unlocking the molecular secrets of oncogenesis.Oncogenesis is a prestigious open access journal, published by SpringerNature, dedicated to advancing our understanding of cancer biology and molecular mechanisms of oncogenesis. Since its inception in 2012, this journal has quickly established itself as a leading platform for innovative research, being ranked in the Q1 quartile in both Cancer Research and Molecular Biology categories for 2023. With an admirable impact factor that reflects its exceptional quality, Oncogenesis is indexed in Scopus, holding notable rankings in both Molecular Biology and Cancer Research, placing in the 87th and 83rd percentile respectively. The journal not only facilitates the dissemination of groundbreaking research but also encourages collaboration among scientists and healthcare professionals across the globe. By offering open access to its articles, Oncogenesis ensures that vital findings reach a diverse audience, fostering a deeper dialogue and understanding in the fight against cancer. Based in the United States but with a global reach, the journal remains committed to publishing high-impact studies that contribute to the advancement of knowledge in the realms of oncology, biochemistry, and genetics.
INTERNATIONAL JOURNAL OF ONCOLOGY
Transforming discoveries into impactful cancer solutions.INTERNATIONAL JOURNAL OF ONCOLOGY is a leading academic publication dedicated to advancing the field of cancer research and treatment. Published by SPANDIDOS PUBL LTD in Greece, this journal, with ISSN 1019-6439 and E-ISSN 1791-2423, has established itself as a reputable source of peer-reviewed articles since its inception in 1993. With an impressive Q2 ranking in both Cancer Research and Oncology categories, as well as high Scopus ranks reflecting its significant contribution to the fields of Medicine and Biochemistry, the journal offers a platform for researchers, clinicians, and students alike to disseminate their findings and engage in dialogue surrounding innovative practices and breakthroughs. Although the journal follows a traditional subscription model, it continues to attract a diverse readership interested in the latest developments in oncological research, providing essential insights into cancer biology, therapeutics, and patient care. With a commitment to excellence, the INTERNATIONAL JOURNAL OF ONCOLOGY plays a vital role in shaping the future of oncology research and is a must-read for anyone passionate about advancing cancer treatment and prevention.